OMISIRGE: payments to doctors
Payments that named OMISIRGE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $395K
- Providers
- 131
- Transactions
- 208
- Average per transaction
- $1,900
The per-transaction average — $1,900 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 131 providers the average total is $3,017, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Gamida Cell Inc. | $395,246 | 100.0% |